Skip to main content

Table 1 Characteristics of participants1 in relation to IDF-defined metabolic syndrome, the HUNT 2 study

From: Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study

 

Men

Women

 

No metabolic syndrome

Metabolic syndrome

No metabolic syndrome

Metabolic syndrome

N (%)

3622 (71.1)

1479 (29.0)

3558 (69.7)

1547 (30.3)

Age, y

45.8 ± 16.6

55.0 ± 16.3

44.8 ± 16.1

60.2 ± 16.2

Systolic BP, mm Hg

136.9 ± 18.7

148.8 ± 19.9

130.1 ± 21.1

153.6 ± 24.3

Diastolic BP, mm Hg

81.2 ± 11.7

88.8 ± 11.7

77.1 ± 11.2

86.7 ± 12.9

Waist circumference, cm

88.2 ± 7.9

101.9 ± 7.3

77.4 ± 9.7

92.9 ± 9.9

HDL cholesterol, mmol/L

1.32 ± 0.33

1.10 ± 0.31

1.59 ± 0.37

1.30 ± 0.36

Triglycerides, mmol/L

1.31 ± 0.91

2.30 ± 1.40

0.99 ± 0.55

2.02 ± 1.15

Glucose, mmol/L

5.35 ± 0.93

5.93 ± 1.67

5.18 ± 0.60

5.98 ± 1.52

Type 2 diabetes, %

0.8

3.6

0.2

6.0

Antihypertensive medication, %

6.6

19.4

5.6

30.2

Waist/hip ratio

0.88 ± 0.05

0.95 ± 0.05

0.78 ± 0.05

0.85 ± 0.06

BMI, kg/m2

25.4 ± 3.0

29.8 ± 3.3

25.0 ± 4.1

30.2 ± 4.5

Total cholesterol, mmol/L

5.74 ± 1.17

6.25 ± 1.14

5.75 ± 1.29

6.69 ± 1.37

  1. Data are numbers, means ± standard deviation, or percentages.
  2. HUNT, the Nord-Trøndelag Health study; IDF, the International Diabetes Federation; BP, blood pressure; HDL, high-density lipoprotein; BMI, body mass index.
  3. 1Fasting ≥4 hours.